Abstract
Introduction
A variety of inflammatory scoring systems and their prognostic value have been reported in many solid organ cancers. This study aimed to examine the association between the systemic and local inflammatory responses, and oncological outcomes in patients undergoing elective surgery for mismatch repair-deficient (dMMR) phenotype colorectal cancer (CRC).
Materials and methods
Consecutive patients undergoing resection for dMMR CRC were identified from a prospectively maintained database and compared with a cohort of patients with proficient mismatch repair system tumours. Systemic inflammatory response was assessed by the modified Glasgow prognostic score (mGPS), neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio, lymphocyte-monocyte ratio, C-reactive protein/albumin ratio, prognostic index and prognostic nutritional index. Local inflammatory response was defined by the presence of tumour infiltrating lymphocytes, tumour infiltrating neutrophils, plasma cells or macrophages at the invasive front. The inflammatory infiltrate was assessed using the Klintrup–Mäkinen (KM) score.
Results
On univariable analysis, preoperative NLR ≥ 5 (hazard ratio [HR] 2.5; 95% confidence interval [CI] 1.25–5.19; p = 0.007) and mGPS (HR 1.6; 95% CI 1.1–2.6; p = 0.03) predicted worse overall survival, but only NLR was associated with greater recurrence (HR 3.6; 95% CI 1.5–8.8; p = 0.004). Increased local inflammatory response, as measured by KM score (HR 0.31; 95% CI 0.1–0.7; p = 0.009) and the presence of macrophages in the peritumoral infiltrate (HR 0.17; 95% CI 0.07–0.3; p < 0.001), was associated with better outcomes. NLR was the only independent prognostic factor of overall and disease-free survival.
Conclusion
Systemic inflammatory response predicts oncological outcomes in CRC patients, but only NLR has prognostic value in the dMMR group.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00384-019-03274-6/MediaObjects/384_2019_3274_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00384-019-03274-6/MediaObjects/384_2019_3274_Fig2_HTML.png)
Similar content being viewed by others
References
Hari DM, Leung AM, Lee JH, Sim MS, Vuong B, Chiu CG et al (2013) AJCC cancer staging manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment? J Am Coll Surg 217:1–16
Kawakami H, Zaanan A, Sinicrope FA (2015) Implications of mismatch repair-deficient status on management of early stage colorectal cancer. J Gastrointest Oncol 6:676–684
Roxburgh CSD, McMillan DC (2012) The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat Rev 38:451–466
Stotz M, Pichler M, Absenger G, Szkandera J, Arminger F, Schaberl-Moser R, Samonigg H, Stojakovic T, Gerger A (2014) The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer 110:435–440
Ryan É, BCh M, Ling Khaw Y, Creavin B, Geraghty R, Ryan E et al (2018) Tumor budding and PDC grade are stage independent predictors of clinical outcome in mismatch repair deficient colorectal cancer. Am J Surg Pathol 42:60–68
Terzić J, Grivennikov S, Karin E, Karin M (2010) Inflammation and colon cancer. Gastroenterology 138:2101–2114
Beal EW, Wei L, Ethun CG, Black SM, Dillhoff M, Salem A, Weber SM, Tran T, Poultsides G, Son AY, Hatzaras I, ** L, Fields RC, Buettner S, Pawlik TM, Scoggins C, Martin RCG, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Schmidt CR (2016) Elevated NLR in gallbladder cancer and cholangiocarcinoma—making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium. HPB 18:950–957
Spolverato G, Maqsood H, Kim Y, Margonis GA, Luo T, Ejaz A, Pawlik TM (2015) Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies. J Surg Oncol 111:868–874
Guo Y-H, Sun H-F, Zhang Y-B, Liao Z-J, Zhao L, Cui J et al (2001) The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis. Oncotarget 8:20011–20024
Väyrynen JP, Tuomisto A, Klintrup K, Mäkelä J, Karttunen TJ, Mäkinen MJ (2013) Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer 109:1839–1847
Klintrup K, Mäkinen JM, Kauppila S, Väre PO, Melkko J, Tuominen H, Tuppurainen K, Mäkelä J, Karttunen TJ, Mäkinen MJ (2005) Inflammation and prognosis in colorectal cancer. Eur J Cancer 41:2645–2654
Drescher KM, Sharma P, Watson P, Gatalica Z, Thibodeau SN, Lynch HT (2009) Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer. Familial Cancer 8:231–239
Pine JK, Morris E, Hutchins GG, West NP, Jayne DG, Quirke P, Prasad KR (2015) Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour. Br J Cancer 113:204–211
Boland CR, Goel A (2010) Microsatellite instability in colorectal cancer. Gastroenterology 138:2073–2087
He EY, Hawkins NJ, Mak G, Roncolato F, Goldstein D, Liauw W, Clingan P, Chin M, Ward RL (2016) The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: an Australian population-based multicenter study. Oncologist 21:618–625
Mohan HM, Ryan E, Balasubramanian I, Kennelly R, Geraghty R, Sclafani F, Fennelly D, McDermott R, Ryan EJ, O’Donoghue D, Hyland JMP, Martin ST, O'Connell PR, Gibbons D, Winter D, Sheahan K (2016) Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer. Eur J Surg Oncol 42:1680–1686
Deschoolmeester V, Baay M, Van Marck E, Weyler J, Vermeulen P, Lardon F et al (2010) Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. BMC Immunol 11:1–12
Edge S, Compton C (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC Cancer Staging Manual and the future of TNM. Ann Surg Oncol 17:1471–1474
McMillan DC (2013) The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39:534–540
Wen J, Bedford M, Begum R, Mitchell H, Hodson J, Whiting FRCSJ et al (2018) The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma. J Surg Oncol 1:1–11
Sakurai K, Tamura T, Toyokawa T, Amano R, Kubo N, Tanaka H, Muguruma K, Yashiro M, Maeda K, Ohira M, Hirakawa K (2016) Low preoperative prognostic nutritional index predicts poor survival post-gastrectomy in elderly patients with gastric cancer. Ann Surg Oncol 23:3669–3676
li WX, hua WF, sheng ZD, zhen QM, Ren C, ** Y et al (2015) A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. BMC Cancer 15:350–361
Jass J, Atkin WS, Cuzick J, Bussey HJ, Morson BC, Northover JM et al (1986) The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 10:437–459
Leitch EF, Chakrabarti M, Crozier JEM, McKee RF, Anderson JH, Horgan PG et al (2007) Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer 97:1266–1270
Fu H, Zheng J, Cai J, Zeng K, Yao J, Chen L, Li H, Zhang J, Zhang Y, Zhao H, Yang Y (2018) Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients after liver transplantation for hepatocellular carcinoma within Hangzhou Criteria. Cell Physiol Biochem 47:293–301
Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K (2017) Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer. Oncol Lett 13:1000–1006
Watt DG, Martin JC, Park JH, Horgan PG, McMillan DC (2015) Neutrophil count is the most important prognostic component of the differential white cell count in patients undergoing elective surgery for colorectal cancer. Am J Surg 210:24–30
Wu Q, Hu T, Zheng E, Deng X, Wang Z (2017) Prognostic role of the lymphocyte-to-monocyte ratio in colorectal cancer. Med (United States) 96:1–5
Patel M, McSorley ST, Park JH, Roxburgh CSD, Edwards J, Horgan PG et al (2018) The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer. Br J Cancer 118:705–713
Bagante F, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, ** LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM (2015) Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma. J Surg Oncol 112:164–172
Kishimoto N, Takao T, Kuribayashi S, Yamamichi G, Nakano K, Kawamura M, Tsutahara K, Tanigawa G, Yamaguchi S (2017) The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy. Int J Clin Oncol 22:153–158
Jia J, Zheng X, Chen Y, Wang L, Lin L, Ye X, Chen Y, Chen D, Dettke M (2015) Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer. Tumor Biol 36:9319–9325
Li M-X, Liu X-M, Zhang X-F, Zhang J-F, Wang W-L, Zhu Y, Dong J, Cheng JW, Liu ZW, Ma L, Lv Y (2014) Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer 134:2403–2413
Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181–184
Wen-Zhuo H, Wan-Ming H, Peng-Fei K, Lin Y, Yuan-Zhong Y, **e Q-K et al (2018) Systemic neutrophil lymphocyte ratio and mismatch repair status in colorectal cancer patients: correlation and prognostic value. J Cancer 9:3093–3100
Park JH, Powell AG, Roxburgh CSD, Horgan PG, McMillan DC, Edwards J (2016) Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment. Br J Cancer 114:562–570
Roxburgh CD, Salmond JM, Horgan P, Oien K, McMillan D (2009) Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 249:788–793
Kennelly RP, Murphy B, Larkin JO, Mehigan BJ, Mccormick PH (2016) Activated systemic inflammatory response at diagnosis reduces lymph node count in colonic carcinoma. World J Gastrointest Oncol 8:623–628
Llosa NJ, Cruise M, Tam A, Wicks EC, Hechenbleikner EM, Taube JM et al (2015) The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov 19:43–51
Mlecnik B, Bindea G, Angell H, Maby P, Angelova M, Tougeron D et al (2016) Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability. Immunity 44:698–711
Le D, Uram J, Wang H, Bartlett B, Kemberling H, Eyring A et al (2015) PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372:2509–2520
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by St. Vincent’s University Hospital Research and Ethics Committee.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 20168 kb)
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Climent, M., Ryan, É.J., Stakelum, Á. et al. Systemic inflammatory response predicts oncological outcomes in patients undergoing elective surgery for mismatch repair-deficient colorectal cancer. Int J Colorectal Dis 34, 1069–1078 (2019). https://doi.org/10.1007/s00384-019-03274-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-019-03274-6